Is intestinal metaplasia of the stomach reversible?
- PMID: 12477745
- PMCID: PMC1773527
- DOI: 10.1136/gut.52.1.1
Is intestinal metaplasia of the stomach reversible?
Abstract
Intestinal metaplasia (IM) of the stomach is a risk factor in developing intestinal-type gastric cancer and hence the question of reversibility is vital. There is emerging epidemiological evidence that with long term follow up, IM may be reversible although a combination of antioxidant agents and eradication of H pylori may be necessary to achieve this. The pathogenesis of IM is currently being elucidated and it is likely that a combination of bacterial, host, and environmental factors will be shown to lead to IM. In assessing gastric cancer risk, histochemical typing of IM will most probably be replaced by molecular markers.
Comment in
-
Atrophic gastritis: pathology and endoscopy in the reversibility assessment.Gut. 2003 Sep;52(9):1387-8. doi: 10.1136/gut.52.9.1387-a. Gut. 2003. PMID: 12912881 Free PMC article. No abstract available.
References
-
- Tosh D, Slack JM. How cells change their phenotype. Nat Rev Mol Cell Biol 2002;3:187–94. - PubMed
-
- You WC, Zhang L, Gail MH et al. Precancerous lesions in two counties of China with contrasting gastric cancer risk. Int J Epidemiol 1998;27:945–8. - PubMed
-
- Shimoyama T, Fukuda S, Tanaka M, et al Evaluation of the applicability of the gastric carcinoma risk index for intestinal type cancer in Japanese patients infected with Helicobacter pylori. Virchows Arch 2000;436:585–7. - PubMed
-
- Sakaki N, Kozawa H, Egawa N, et al Ten-year prospective follow-up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings. Aliment Pharmacol Ther 2002;16(Suppl 2):198–203. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical